当前位置: 首页 > 期刊 > 《血液学杂志》 > 2004年第4期 > 正文
编号:10586089
Identification and characterization of EBP a novel EEN binding protein that inhibits Ras signaling and is recruited into the nucleus by the MLL-EEN f
http://www.100md.com 《血液学杂志》2004年第4期
     From the Department of Pathology and Department of Biochemistry, The University of Hong Kong; and Department of Pathology, Stanford University, Palo Alto, CA.%3;&}9\, 百拇医药

    The chimeric MLL-EEN fusion protein is created as a result of chromosomal translocation t(11;19)(q23;p13). EEN, an Src homology 3 (SH3) domain–containing protein in the endophilin family, has been implicated in endocytosis, although little is known about its role in leukemogenesis mediated by the MLL-EEN fusion protein. In this study, we have identified and characterized EBP, a novel EEN binding protein that interacts with the SH3 domain of EEN through a proline-rich motif PPERP. EBP is a ubiquitous protein that is normally expressed in the cytoplasm but is recruited to the nucleus by MLL-EEN with a punctate localization pattern characteristic of the MLL chimeric proteins. EBP interacts simultaneously with EEN and Sos, a guanine-nucleotide exchange factor for Ras. Coexpressoin of EBP with EEN leads to suppression of Ras-induced cellular transformation and Ras-mediated activation of Elk-1. Taken together, our findings suggest a new mechanism for MLL-EEN–mediated leukemogenesis in which MLL-EEN interferes with the Ras-suppressing activities of EBP through direct interaction.(Judy Wai Ping Yam Dong-Yan Jin Chi Wai So and Li Chong Chan)